2Back M. Functional characteristics of cysleinyl-leukotriene receptor subtypes. Life Sci,2002,71:611 622.
3Nagata M, Saito K, Tsuchiya K.el al. Leukotriene D4 upregulates eosinophil adhesion via the cysteinyl leukotriene l receptor. J Allcrgy Clin Immunol, 2002,109 : 676-680.
4Minoguchi K, Kohno Y, Minoguchi H, et al. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest,2002,121:732-738.
5Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP). soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma. J Allergy Clin Immunol.2002.109:257 263.
6Henderson WR Jr,Tang LO,Chu SJ,et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med,2002,165:108-116.
7Braccioni F, Dorman SC, O'byrne PM, et al. The effect of cysteinyt teukotrienes on growth of eosinophit progenitors from peripheral blood and bone marrow of atopic .subjects. J Allergy Clin Immunot,2002,110:96-101.
8Lee E, Robertson T, Smith J, et al. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuaIs. Am J Respir Crit Care Med, 2000,161:1881-1886.
9Lee E,Lindo T,Jackson N,et al. Reversal of human neutrophil survival by leukotriene B ( 4 ) receptor blockade and5-lipoxygenase and 5-lipoxygenase activating prolein inhibitors.Am J Respir Crit Care Med,1999,160:2079-2085.
10Melis M,Siena L,Pace E,et al. Fluticasone induces apoptosis in peripheral T-lymphocytes:a comparison between asthmatic and normal subjects. Eur Respir J ,2002,19:257-266.
